{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Type 2 Diabetes: A Pharmacologic Update

Purpose of Activity

To provide information about established as well as more recently introduced type 2 diabetes treatments and the nursing implications for patient teaching and monitoring for adverse effects.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Outline indications and contraindications for the drugs discussed in this article.
  2. Identify adverse effects related to these drugs.
  3. Summarize key points for patient teaching about these drugs.
Price: $17.95

Credits:

  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours







Test Code: AJN0319B
Published: March 2019
Expires: 3/5/2021
Passing Score: 14/20 (70%)
Authors: Patricia Keresztes, PhD, MSN, RN; Annette Peacock-Johnson, DNP, MSN, RN